Abpro Holdings, Inc. (ABPO): Nasdaq/NYSE listing notice — Abpro Holdings receives Nasdaq minimum bid price deficiency notice; 180-day cure period.

Abpro Holdings, Inc.

Received Nasdaq notice on April 2, 2025, for failure to meet $1.00 minimum bid price requirement.
Closing bid price below $1.00 for 30 consecutive business days triggers the deficiency.
Company has 180 calendar days, until September 29, 2025, to regain compliance.
To regain compliance, common stock must close at $1.00+ for 10 consecutive business days.
If not cured by Sept 29, may qualify for an additional 180-day compliance period.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Abpro Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5450(a)(1), 5810(c)(3)(A)

Exact text from the filing

April 2, 2025, Abpro Holdings, Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that, based on the closing bid price of the Company’s common stock for the last 30 consecutive business days, the Company no longer complies with the minimum bid price requirement for continued listing on The Nasdaq Stock Market LLC. Nasdaq Listing Rule 5450(a)(1) requires listed securities to maintain a minimum bid price of $1.00 per share (the “Minimum Bid Price Requirement”), and Nasdaq Listing Rule

View on SEC.gov

Browse all listing & compliance notices →

Abpro Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-029927

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.